1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル

Manidipine

HCID 4008CAS 89226-50-6

基本情報

標準SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1
InChIKey
ANEBWFXPVPTEET-UHFFFAOYSA-N
分子式
C35H38N4O6
平均分子量
610.7 g/mol
単同位体質量
610.27913494

名称と識別子

優先名称
Manidipine
IUPAC
5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
現地名
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル
英語名
Manidipine
分子式
C35H38N4O6
分子量
610.7

名称と別名

manidipine89226-50-6FranidipineArtedilManidipine 6300Manidipino5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate6O4754US88DTXSID20437452-(4-Diphenylmethyl-1-piperazinyl)ethyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate3-{2-[4-(diphenylmethyl)piperazin-1-yl]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipinum
名称をさらに表示
1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸5-メチル3-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]マニジピン1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)ピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル]5-メチル2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]5-メチル1,4-ジヒドロ-2,6-ジメチル-4-(3-ニトロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-[2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル]3-{2-[4-(ジフェニルメチル)ピペラジン-1-イル]エチル} 5-メチル 2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボキシラート2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸3-[2-[4-(ジフェニルメチル)ピペラジノ]エチル]5-メチル2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸=3-{2-[4-(ジフェニルメチル)-1-ピペラジニル]エチル}=5-メチルManidipine (Manyper)IpertenManidipine(base)Manidipine(CV-4093)Manidipine Impurity1254Manidipine (10mM in DMSO)
3-(2-(4-(diphenylmethyl)piperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate5-O-(2-(4-benzhydrylpiperazin-1-yl)ethyl) 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylatemanidipine, (+-)-RefChem:809939DTXCID0023745C08CA11120092-68-43-(2-(4-Benzhydrylpiperazin-1-yl)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

データベース識別子

CAS
89226-50-6
PubChem CID
4008
DTXSID
DTXSID2043745
ChEMBL
CHEMBL1085699、CHEMBL312176
ChEBI
CHEBI:135849
UNII
6O4754US88
EC Number
855-394-4
Nikkaji
J313.870D

物性

構造計算による物性

XLogP
5.6
極性表面積
117 Ų
水素結合供与体数
1
水素結合受容体数
9
回転可能結合数
11
重原子数
45

実験および物理化学的性質

Solubility<1mg/mL

物理化学的性質

融点
125 · 125-128°C
沸点
722 · 722.0±60.0 °C(Predicted)
比重(密度)
1.232 · 1.232±0.06 g/cm3(Predicted)
貯蔵温度
2 · Sealed in dry,2-8°C
溶解性
10 mM · Soluble in DMSO > 10 mM
外見
Powder

化学的性質

化学的特性Light Yellow Crystalline Solid

安全と法規制

GHS分類

GHS Classification · 5 件

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 1 notifications to the ECHA C&L Inventory.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Regulatory InformationStatus: Active Update: 11-04-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/33372
Hazard Classes and CategoriesAcute Tox. 3 (100%)

毒性情報

Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Manidipine

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

法規制情報

Regulatory InformationStatus: Active Update: 11-04-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/33372

安全データ

注意喚起語
警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system;C08 - Calcium channel blockers;C08C - Selective calcium channel blockers with mainly vascular effects;C08CA - Dihydropyridine derivatives;C08CA11 - Manidipine

QC - Cardiovascular system;QC08 - Calcium channel blockers;QC08C - Selective calcium channel blockers with mainly vascular effects;QC08CA - Dihydropyridine derivatives;QC08CA11 - Manidipine

Protein BindingManidipine is 99% bound to human plasma proteins.
PharmacodynamicsManidipine produces vasodilation resulting in lower blood pressure.
Mechanism of Action · 1 件

Contraction of vascular smooth muscle is stimulated by Gq coupled receptors which produce calcium release from the sarcoplasmic reticulum. This is followed by opening of voltage dependent calcium channels and an influx of calcium into the cell ultimately producing contraction. Manidipine binds to and dissociates slowly from L- and T-type voltage dependent calcium channels on smooth muscle cells, blocking the entrance of extracellular calcium into the cell and preventing this contraction. This produces vasodilation which decreases blood pressure. Manidipine produces renal vasodilation and an increase in natriuresis. This likely contributes to the antihypertensive effect by reducing blood volume. Manidipine is selective for the vasculature and does not produce significant effects on the heart or central nervous system at clinically relevant dosages.

Biological Half-LifeThe half life of elimination has been observed to be dose dependent. Doses of 5, 10, and 20 mg produced half lives of 3.94, 5.02, and 7.95 h respectively.
Metabolism/MetabolitesManidipine is extensively metabolized by CYP enzymes to pyridine derivatives and diphenylmethane derivatives which make up 4-7% and 22-24% of the dose excreted in the urine.

用途と製造

UsesUse (kg; approx.) in Germany (2009): >25;Consumption (g per capita; approx.) in Germany (2009): 0.000305;Calculated removal (%): 83.1
応用分野 · 2 件

説明Manidipine is a dihydropyridine L- and T-type calcium channel blocker. It blocks recombinant rabbit L-type (α1Cα2/δβ1a) and human T-type (α1H) calcium channels expressed in Xenopus oocytes and native L-type channels in dissociated guinea pig cardiac ventricular cells (IC50 = 2.6 nM). Manidipine inhibits intracellular calcium increases induced by endothelin-1 (ET-1; ) in A7r5 rat vascular smooth muscle cells (ED50 = 1 nM) and potassium-induced contraction of isolated dog femoral and portal veins (IC50s = 24 and 2.1 nM, respectively). In vivo, it lowers blood pressure in spontaneously hypertensive rats (SHRs) when administered at a dose of 10 mg/kg and inhibits left ventricular hypertrophy in rats induced by isoproterenol when administered at a dose of 3 mg/kg. Formulations containing manidipine have been used in the treatment of hypertension.

使用Manidipine (Manyper) is a lipophilic, third-generation, highly vasoselective dihydropyridine calcium antagonist with an IC50 of 2.6 nM. It causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. It

サプライヤー50 社

济南百隆化学有限公司[email protected] · [email protected]
成都超九八生物科技有限公司13348960310 13348960310 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
爱斯特(成都)生物制药股份有限公司+86-28-85122536 85324413 · [email protected]

関連反応

2 件

関連ノート

読み込み中…